The pathophysiology of ovarian hyperstimulation syndrome - Views and ideas

Human Reproduction

Volumn 12, Issue 6, 1997, Pages 1129-1137

  Elchalal, Uriel ^a   Schenker, Joseph G ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Interleukins; Ovarian hyperstimulation syndrome; Pathophysiology; Vascular endothelial growth factor

Indexed keywords

CHORIONIC GONADOTROPIN; CYTOKINE; ENDOTHELIN 1; ESTROGEN; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN DERIVATIVE; PROLACTIN; PROSTAGLANDIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASOACTIVE AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; CAPILLARY PERMEABILITY; CLINICAL FEATURE; DEATH; FEMALE; HEMOCONCENTRATION; HUMAN; HYPOVOLEMIC SHOCK; KIDNEY FAILURE; OLIGURIA; OVARY CYST; OVARY DISEASE; OVARY HYPERTROPHY; OVULATION INDUCTION; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PERITONEAL FLUID; PLEURA FLUID; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SIDE EFFECT;

EID: 0030949627     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.6.1129     Document Type: Review

References (103)

1. Abramov, Y., Schenker, J.G., Lewin, A. et al. (1996) Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum. Reprod., 11, 1381-1386.
2. Abramov, Y., Barak,V., Nisman B. and Schenker, J.G. (1997) Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil. Steril., 67, 261-265.
3. Adashi, E.Y. (1990) The potential relevance of cytokines to ovarian physiology: the emerging role of resident ovarian cells of the white blood cell series. Endocr. Rev., 11, 454-64.
4. Adashi, E., Resnick, C., Packman, J.N. et al. (1990) Cytokine-mediated regulation of ovarian function: tumor necrosis factor alpha inhibits gonadotrophin-supported progesterone accumulation by differentiating and luteinized murine granulosa cells. Am. J. Obstet. Gynecol., 162, 889-896.
5. Araujo, E. Jr, Bernardini, L., Frederick, J.L. et al. (1994) Prospective randomized comparison of human chorionic gonadotrophin versus intramuscular progesterone for luteal-phase support in assisted reproduction. J. Assist. Reprod. Genet., 11, 74-78.
6. Bagavandoss, P., Kunkel, S.L., Wiggins, R.C. and Keyes, P.L. (1987) Tumor necrosis factor-α (TNF-α) production and localization of macrophages and T lymphocytes in the rabbit corpus luteum. Endocrinology, 122, 1185-1187.
7. Balasch, J., Tur, R., Creus, M. et al. (1994) Triggering of ovulation by a gonadotrophin releasing hormone agonist in gonadotrophin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy. Gynecol. Endocrinol., 8, 7-12.
8. Balasch, J., Arroyo, V., Carmona, F. et al. (1991) Severe ovarian hyperstimulation syndrome: role of peripheral vasodilatation. Fertil. Steril., 56, 1077-1083.
9. Balasch, J., Arroyo, V., Fabregues, F. et al (1995) Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome. Fertil. Steril., 64, 65-68.
10. Beutler, B. and Cerami, A. (1986) Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature, 320, 585-588.
11. Blumenfeld, Z., Lang, N., Amit, A. et al. (1994) Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction. Fertil. Steril., 62, 456-460.
12. Borenstein, R., Elchalal, U., Lunenfeld, B. and Shoham Schwartz, Z. (1989) Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach. Fertil. Steril., 51, 791-795.
13. Buyalos, R.P., Watson, J.M. and Martinez-Maza, O. (1992) Detection of IL-6 in human follicular fluid. Fertil. Steril., 57, 1230-1234.
14. Cannon, J.G. and Dinarello, C.A. (1985) Increased plasma Interleukin-1 activity in women after ovulation induction. Science, 227, 1247-1249.
15. Castell, J.V., Gomez-Lechon, M.J., David, M. et al. (1988) Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett., 234, 17.
16. Culler, M.D., Tarlatzis, B.C., Lightman, A. et al. (1986) Angiotensin II-like immunoreactivity in human ovarian follicular fluid. J. Clin. Endocrinol. Metab., 62, 613-615.
17. Darbon, J.M., Oury, F., Laredo, J. and Bayard, F. (1989) Tumor necrosis factor-α inhibits follicle-stimulating hormone-induced differentiation in cultured rat granulosa cells. Biochem. Biophys. Res Commun., 163, 1038-1046.
18. Davis, J.S. (1960) Hormonal control of plasma and erythrocyte volume of rat uterus. Am. J. Physiol., 199, 841-846.
19. Delbaere, A. Bergmann, P.J., Gervy-Decoster, C. et al. (1994) Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Fertil. Steril., 62, 731-737.
20. Dinarello, C.A. (1989) Interleukin-1 and its related cytokines. Adv. Immunol., 44, 153-205.
21. Dinarello, C.A. (1984) Interleukin-1 and the pathogenesis of the acute-phase response. New Engl. J. Med., 311, 1413-1418.
22. Duff, G. (1985) Many roles for interleukin-1. Nature, 313, 352.
23. Engel, T., Jewelewicz, R., Dyrenfurth, I. et al. (1972) Ovarian hyperstimulation syndrome: report of a case with notes on pathogenesis and treatment. Am. J. Obstet. Gynecol., 112, 1052-1060.
24. Erlik, Y., Naot, Y., Friedman, M. et al. (1979) Histamine levels in ovarian hyperstimulation syndrome. Obstet. Gynecol., 53, 580-582.
25. Fernandez, L.A., Tarlatzis, B.C., Rzasa, Q.J. et al. (1985) Renin like activity in ovarian follicular fluid. Fertil. Steril., 44, 219-223.
26. Fernandez, C.A., Twickler J. and Mead, A. (1985) Neovascularization produced by angiotensin II. J. Lab. Clin. Med., 105, 141-145.
27. Filep, J.G., Sirois, M.G., Foldes-Filep, E. et al. (1993) Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors. Br. J. Pharmacol., 109, 880-886.
28. Finkel, M.S., Oddis, C.V., Jacob, T.D. et al. (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science, 257, 387-389.
29. Frederick, J.L., Shimanuki, T. and DiZerega, G.S.(1984) Initiation of angiogenesis by human follicular fluid. Science, 224, 389-392.
30. Friedlander, M.A., Loret de Mola, J.R. and Goldfarb, J.M. (1993) Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil. Steril., 60, 826-833.
31. Fukuoka, M., Mori, T., Taii, S. and Yasuda, K. (1988) Interleukin-1 inhibits luteinization of porcine granulosa cells in culture. Endocrinology, 122, 367-369.
32. Geiger, T., Andus, T., Klapproth, J. et al. (1988) Induction of rat acute-phase proteins by interleukin-6 in vivo. Eur. J. Immunol., 18, 717-721.
33. Gerris, J., De-Vits, A., Joostens, M. and Van-Royen, E. (1995) Triggering of ovulation induction in human menopausal gonadotropin-stimulated cycles: comparison between intravenously administered gonadotropin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotropin (10 000 IU). Hum. Reprod., 10, 56-62.
34. Goldchmit R., Elchalal U., Zalel, Y. et al. (1993) Hypovolaemic shock as a presenting sign of severe hyperstimulation syndrome following in vitro fertilization and embryo transfer (IVF-ET). J. Assist. Reproduct. Genet., 10, 480-482.
35. Goldsman, M.P., Pedram, A., Dominguez, C.E. et al. (1995) Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of of the hyperstimulation syndrome. Fertil. Steril., 63, 268-272.
36. Gottschall, P.E., Katsuura, G. and Arimura, A. (1989) Interleukin-1 suppresses follicle stimulating hormone-induced oestradiol secretion from cultured ovarian granulosa cells. J. Reprod. Immunol., 15, 281-290.
37. Gottschall, P.E., Katsuura, G., Hoffman, S.T. and Arimura, A. (1988) Interleukin-1: an inhibitor of luteinizing hormone receptor formation in cultured rat granulosa cells. FASEB J., 2, 2492-2496.
38. Gray, P.W., Glaister, D., Chen, E. et al. (1986) Two interleukin 1 genes in the mouse: Cloning and expression of the cDNA for murine interleukin 1 beta. J. Immunol., 137, 3644-3648.
39. Grochowski, D., Sola, E., Kulikowski, M. et al. (1995) Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis. J. Assist. Reprod. Genet., 12, 394-396.
40. Hack, C.E., DeGroot, E.R., Felt-Bersma, R.J.F. et al. (1989) Increased plasma levels of interleukin-6 in sepsis. Blood, 74, 1704-1710.
41. Hirano, T., Yasukawa, K., Harada, H. et al. (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature, 324, 73-76.
42. Hollenberg, S.M., Cunnion, R.E. and Parillo, J.E. (1991) The effect of tumor necrosis factor on vascular smooth muscle. Chest, 100, 1133-1137.
43. Hume, D.A., Halpin, D., Charlton, H. and Gordon, S. (1984) The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F 4/80: macrophages of endocrine organs. Proc. Natl. Acad. Sci. USA, 81, 4174-4177.
44. Hurwitz, A., Milwidsky, A., Yagel, S. and Adoni, A. (1983) Early unwinding of torsion of an ovarian cyst as result of hyperstimulation syndrome. Fertil. Steril., 40, 393-394.
45. Hurwitz, A., Loukides, J., Ricciarelli, E. et al. (1992) Human ovarian interleukin-1 (IL-I) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist. J. Clin. Invest., 89, 1746-1754.
46. Itskovitz, A., Sealey, J.E., Glorioso, N. and Rosenwaks, Z. (1987) Plasma prorenin response to human chorionic gonadotropin in ovarian hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations. Proc. Natl Acad. Sci. USA, 84, 7285-7289.
47. Jewelewicz, R. and Vande Wiele, R.L. (1975) Acute hydrothorax as the only symptom of ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol., 121, 1121.
48. Kamada, S., Kubota, T., Taguchi, M. and Aso, T. (1993) High levels of immunoreactive endothelin-1 in human follicular fluids. Hum. Reprod., 8, 674-677.
49. Katz, Z., Lancet, M., Borenstein, R. and Chemke, J. (1984) Absence of teratogenicity of indomethacin in ovarian hyperstimulation syndrome. Int. J. Fertil., 29, 186-188.
50. Khan, S.A., Schmidt, K., Hallin, P. et al. (1988) Human testis cytosol and ovarian follicular fluid contain high amounts of interleukin-1-like factor(s). Mol. Cell. Endocrinol., 58, 221-230.
51. Knox, G.E. (1974) Antihistamine blockade of the ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol., 118, 992-994.
52. Knox, G.E. , Dowd, A. J., Spiesel, S.A. and Hong, R. (1975) Antihistamine blockade of the ovarian hyperstimulation syndrome, II: possible role of antigen-antibody complexes in the pathogenesis of the syndrome. Fertii. Steril., 26, 418-421.
53. Konickx, P.R., Rnaer, M. and Brosens, I.A. (1980) Origin of peritoneal fluid in women. An ovarian exudation product. Br. J. Obstet Gynaecol., 87, 177-183.
54. Krasnow, J.S., Berga S.L., Gusick, D.S. et al. (1996) Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril., 65, 552-555.
55. March, C.J., Mosley, B., Larsen, A. et al. (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNA's. Nature, 315, 641-647.
56. McClure, N., Leya, J., Radwanska, E. et al. (1992) Luteal phase support and severe ovarian hyperstimulation syndrome. Hum. Reprod., 7, 758-764.
57. McClure, N., Healy, D.L., Rogers, P.A.W. et al. (1994) Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet, 344, 235-236.
58. Meirow, D., Schenker, J.G. and Rosler, A. (1996) Ovarian hyperstimulation syndrome with low oestradiol in non classic 17alpha-hydroxylase, 17, 20-lyase deficiency: What is the role of oestrogens? Hum. Reprod., 11, 2119-2121.
59. Mordel, N. and Schenker, J.G. (1993) Gonadotropin releasing hormone agonist and ovarian hyperstimulation syndrome in assisted reproduction. Hum. Reprod., 8, 2009-2014.
60. Morris, R.S. and Paulson, R.J. (1994) Ovarian derived prorenin angiotensin cascade in human reproduction. Fertil. Steril., 62, 1105-1114.
61. Morris, R.S., Wong, I.L., Kirkman E. et al. (1995) Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum. Reprod., 10, 1355-1358.
62. Motro, B., Itin, A., Sachs, L. and Keshet, E. (1990) Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Cell Biol., 87, 3092-3096.
63. Nakamura, Y., Smith, M., Krishna, A. and Terranova, P.F. (1987) Increased number of mast cells in the dominant follicle of the cow; Relationship among luteal, stromal, and hilar regions. Biol. Reprod., 37, 546-549.
64. Natanson, C., Eichenholz, P.W., Danner, R.L. et al. (1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med., 169, 823-832.
65. Navot, D., Margalioth, E.J., Laufer, N. et al. (1987) Direct correlation between plasma renin activity and severity of ovarian hyperstimulation syndrome. Fertil. Steril., 48, 57-61.
66. Navot, D., Relou, A., Birkenfeld, A. et al. (1988) Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol., 159, 210-215.
67. Navot, D., Bergh, P.A. and Laufer, N. (1993) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
68. Neulen, J., Yan, Z., Raczek, S. et al. (1995) Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab., 80, 1967-1971.
69. Nijsten, M.W.N., De Groot, E.R., Ten Duis, J.H. et al. (1987) Serum levels of interleukin-6 and acute phase responses. Lancet, ii, 921.
70. Okusawa, S., Gelfand, J.A., Ikefima, T. et al. (1988) Interleukin 1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest., 81, 1162-1172.
71. Ong, A.C.M., Eisen, V., Rennie, D.P. et al. (1991) The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin. Clin. Endocrinol., 34, 43-49.
72. Orvieto, R., Voliovich, I., Fishman, P. and Ben-Rafael, Z. (1995) Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. Hum. Reprod., 10, 24-27.
73. Pappan, G.D. and Blanchette, E.J. (1965) Transport of colloidal particles from small blood vessels correlated with cyclic changes in permeability. Invest. Ophthalmol., 4, 1026-1031.
74. Pessina, A.C., Hulme, B. and Peart, W.S.(1972) Renin-induced proteinuria and the effects of adrenalectomy, II: morphology in relation to function. Proc. R. Soc. Lond. (Biol.), 180, 61-71.
75. Phillips, H.S., Hains, J., Leung, D.W. and Ferrera, N. (1990) Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology, 127, 965-967.
76. Polishuk, W.Z. and Schenker, J.G. (1969) Ovarian overstimulation syndrome. Fertil. Steril., 20, 433-450.
77. Prado, G.N.,Thomas, K.M., Suzuki, H. et al. (1994) Molecular characterization of a novel rabbit interleukin-8 receptor isotype. J. Biol. Chem., 269, 1239-1241.
78. Preiser, J.C., Schmartz, D., Van der Linden, P. et al. (1991) IL-6 administration has no acute haemodynamic or hematologic effect in the dog. Cytokine, 3, 1-4.
79. Pride, J. and Ho, Y. I. (1990) The ovarian hyperstimulation syndrome. Semin. Reprod. Endocrinol., 8, 247-253.
80. Pride, S.M., Yuen, B.H., Moon, Y.S. and Leung, P.C.S. (1986) Relationship of gonadotropin-releasing hormone, danasol and prostaglandin blockade to ovarian hyperstimulation syndrome in the rabbit. Am. J. Obstet. Gynecol., 154, 1155-1160.
81. Rabau, E., David, A., Serr, D.M. et al. (1967) Human menopausal gonadotropin for anovulation and sterility. Results of 7 years of treatment. Am. J. Obstet. Gynecol., 96, 92-98.
82. Ravel, A., Barak, V., Lavy, Y. et al. (1996) Characterization of intraperitoneal cytokines and nitrites in women with severe OHSS - A multicenter study. Fertil. Steril., 66, 66-71.
83. Ravindranath N., Little-Ihrig, L., Phillips, H.S. et al. (1992) Vascular endothelial growth factor mRNA expression in the primate ovary in relation to follicular growth and corpus luteum function. Endocrinol., 2065, 254-260.
84. Robertson, D., Selleck K., Suikkari A.M. et al. (1995) Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment. Hum. Reprod., 10, 2478-2482.
85. Schenker, J.G. (1993) Prevention and treatment of ovarian hyperstimulation. Hum. Reprod., 8, 653-659.
86. Schenker, J.G. and Polishuk, W.Z. (1967) Ascites in cases of twin pregnancy. J. Obstet. Gynaecol. Br. Commomw., 74, 451-452.
87. Schenker, J.G. and Polishuk, W.Z. (1976) The role of prostaglandins in ovarian hyperstimulation syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol., 6, 47-52.
88. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: A current survey. Fertil. Steril., 30, 255-268.
89. Senger, D.R., Galli, S.J., Dvorak, A.M. et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219, 983-985.
90. Shalev, E., Geslevich, Y. and Ben-Ami, M. (1994) Induction of pre-ovulatory luteinizing hormone surge by gonadotropin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome. Hum. Reprod., 9, 417-419.
91. Shoham, Z., Weissman, A., Borenstein, R. et al. (1994) Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in-vitro fertilization program: a prospective, randomized, placebo-controlled study. Fertil. Steril., 62, 137-142.
92. Shweiki, D., Itin, A., Neufeld, G. et al. (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and (VEGF) receptors in mice, suggest a role in hormonally regulated angiogenesis
93. Takakura, K., Taii, S., Fukuoka, M. et al. (1989) Interleukin-2 receptor/p55 (Tac)-inducing activity in porcine follicular fluid. Endocrinology, 125, 618-623.
94. Thaler, I. Yoffe N., Kaftory, J.K. and Brandes, J.M. (1981) Treatment of ovarian hyperstimulation syndrome: the physiological basis for a modified approach. Fertil. Steril., 36, 110-113.
95. Todorow, S., Schricker, S.T., Siebzehruebl, E.R. et al. (1993) von Willebrand factor: an endothelial marker to monitor in-vitro fertilization patients with ovarian hyperstimulation syndrome. Hum. Reprod., 8, 2039-2046.
96. Tollan, A. Holst, N., Forsdahl, F. et al. (1990) Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization. Am. J. Obstet. Gynecol., 162, 554-558.
97. Tsirigotis, M. and Craft, I., (1994) Ovarian hyperstimulation syndrome (OHSS): how much do we really know about it? Eur. J. Obstet. Gynecol., 55, 151-155.
98. Waage, A., Brandtzaeg, P., Halstensen, A. et al. (1989) The complex pattern of cytokines in plasma from patients with meningococcal septic shock: association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med., 169, 333-338.
99. Watson, J.M., Sensintaffar, F.L., Berek, J.S. and Martinez-Maza O. (1990) Constitutive production of IL-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res., 50, 6959-6965.
100. Weinberg, J.R., Wright, D.J.M. and Guz, A. (1988) Interleukin-1 and tumor necrosis factor cause hypotension in the conscious rabbit. Clin. Sci., 75, 251-255.
101. Yarali, H., Fleige-Zahradka, B.G., Yuen, B.H. and McComb, P.F. (1993) The ascites in ovarian hyperstimulation syndrome does not originate from the ovary. Fertil. Steril., 59, 657-661.
102. Zaides, I., Friedman, M., Lindenbaum, E.S. et al. (1983) Serotonin and the ovarian hyperstimulation syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol., 15, 55-61.
103. Zolti, M., Ben-Rafael, Z., Meirom, R. et al. (1991) Cytokine involvement in oocyte and early embryos. Fertil. Steril., 56, 265-272.